EBAA Regulatory Alert: Monkeypox
EBAA Regulatory Alert: FDA Releases Important Information for HCT/P Establishments Regarding Monkeypox Virus and HCT/P Donation August 29, 2022 FDA released a new safety communication for human cells, tissues, or cellular or […]
Informational Alert: HTLV I/II and Eye Tissue Donation
The Policy and Position Review Subcommittee (PPRS) of the EBAA Medical Advisory Board has reassessed what is currently known about the risk of transmission of Human T-lymphotropic virus (HTLV) via […]
ALERT: CRITICAL SUPPLY ISSUE: BioRad HIV 1/2 Plus O EIA Assay
On May 5, EBAA alerted the membership about a critical supply issue with the BioRad HIV 1/2 Plus O EIA Assay through an All Member post in The Lens. Two […]
Eclipse
Eye Safety Tips for the 2024 Total Eclipse On Monday, April 8, 2024 parts of the southern and eastern United States are set to experience a total solar eclipse and […]
Regulatory Alert: FDA Inspectional Focus on Donor Eligibility With Regard to Sepsis
BACKGROUND Several recent FDA inspections of eye banks have resulted in Form FDA 483, Inspectional Observations, for not determining donors to be ineligible with a diagnosis of sepsis. All cited […]
Informational Alert: Chagas Disease and Eye Tissue Donation
The Policy & Position Review Subcommittee (PPRS) of the EBAA Medical Advisory Board has reviewed the currently available evidence regarding Chagas disease and eye tissue donation. As Chagas disease becomes […]
FDA Revises Implementation Dates for Sepsis and Mtb Guidances
The FDA has announced a revised implementation date of May 4, 2025, for its recently issued guidance documents: While the guidance documents remain final, FDA’s decision to delay implementation reflects a […]
PPRS Informational Alert: Updated COVID-19 Screening Recommendations
The Policy & Position Review Subcommittee (PPRS) of the EBAA Medical Advisory Board continues to review its guidance and screening recommendations regarding COVID-19. Given that COVID-19 is now endemic in […]
